JP Morgan Chase’s BiomX PHGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$552 Sell
1,538
-12,597
-89% -$14.5K ﹤0.01% 7408
2026
Q1
$63.5K Hold
14,135
﹤0.01% 6082
2025
Q4
$26.4K Sell
14,135
-8,497
-38% -$57.2K ﹤0.01% 6442
2025
Q3
$226K Hold
22,632
﹤0.01% 5454
2025
Q2
$194K Hold
22,632
﹤0.01% 5247
2025
Q1
$239K Buy
22,632
+1
+0% +$14 ﹤0.01% 5168
2024
Q4
$314K Buy
+22,631
New +$322K ﹤0.01% 5280
2022
Q2
Sell
-3
Closed -$1K 6771
2022
Q1
$1K Buy
+3
New +$892 ﹤0.01% 6490

Other funds holding PHGE

JP Morgan Chase's PHGE Position: Q2 2026 in Review

JP Morgan Chase reduced its BiomX (PHGE) stake by 89% in Q2 2026, selling an estimated $14.5K and leaving 1,538 shares worth $552. The position accounts for ﹤0.01% of the portfolio, ranked #7408.

JP Morgan Chase first reported a position in PHGE in Q1 2022 and has held it in 8 quarters since. The position peaked at $314K in Q4 2024. 9 funds tracked by Wall St. Rank hold PHGE as of Q2 2026.

  • JP Morgan Chase held 1,538 shares of BiomX worth $552 as of Q2 2026.
  • JP Morgan Chase sold 12,597 BiomX shares in Q2 2026, an estimated $14.5K.
  • BiomX made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7408 holding.
  • JP Morgan Chase first reported a position in BiomX in Q1 2022 and has held it in 8 quarters since.
  • JP Morgan Chase's BiomX position peaked at $314K in Q4 2024.
  • 9 funds tracked by Wall St. Rank held BiomX as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.